Page 45 - கால்நடை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கால்நடை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கால்நடை Today - Breaking & Trending Today

Chills of the Good Kind Await the Winter Backpacker, Without Crowds


For 21 years, I have led an overnight backpacking excursion to a different wild spot in Pennsylvania on a cold, preferably snowy, winter weekend.
We don’t do it to prove our mettle, but to immerse ourselves in a landscape of sights, sounds and light experienced at no other time of year. It’s also an antidote to seasonal affective disorder.
Nearly each year, several people among us are experiencing winter hiking and camping for the first time. Sometimes overcoming a lifetime of trepidation, they are thrilled to learn that being outdoors when it’s freezing can be quite comfortable as long as they are wearing appropriate layers of clothing and bring the right gear. ....

United States , Kenny Fletcher , Camping Has Its Own Unique , Appalachian Trail , Enjoying Cold Weather , Sleeping Bag , Textile Industry , Long Underwear , Synthetic Material , ஒன்றுபட்டது மாநிலங்களில் , கெண்ணி பிளெட்சர் , முகாம் உள்ளது அதன் ஓந் தனித்துவமான , அபலாசியன் பாதை , அனுபவிக்கிறது குளிர் வானிலை , தூங்குகிறது பை , வானிலை ஆய்வு , ஜவுளி தொழில் , நீண்டது உள்ளாடை , செயற்கை பொருள் ,

Applied DNA Sciences, Inc.: Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA COVID-19 Vaccine Candidate for Feline Veterinary Market


(2)
- Vaccine Candidate Previously Demonstrated Antibodies and T-cell Response in Mouse Models
- Clinical Trial to Serve as Initial Validation of LinearDNA Platform in Large Mammals with Potential Advantages in Manufacturing, Storage, and Distribution over Other Vaccines
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company ), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ( Evvivax ), today announced the initiation of Phase I of a two-phase clinical trial to evaluate a LinearDNA COVID-19 vaccine candidate for the feline veterinary market. The goal of the trial is to evaluate the vaccine candidate as a strategy for the prevention of SARS-CoV-2, the virus that causes COVID-19, in feline companions of humans that may mitigate the animals as a potential reservoir for infections in humans. If successful, the clinical trial will also serve as an important initial validation of LinearDNA, Appl ....

United States , Joseph Impellizeri , Jamesa Hayward , Luigi Aurisicchio , Us Department Of Agriculture , Sciences Inc , Drug Administration , Veterinary Oncology Services At Guardian Specialists , Securities Exchange , American Veterinary Medical Association , Plant Health Inspection Service , Candidate Previously Demonstrated Antibodies , T Cell Response , Mouse Models , Initial Validation , Large Mammals , Potential Advantages , Polymerase Chain Reaction , Takis Biotech , Veterinary Oncology Services , Guardian Veterinary Specialists , Supervising Investigator , American College , Veterinary Internal Medicine , Russell Microcap , Looking Statements ,